Moneycontrol launches Analysts’ Call Tracker. A monthly special page that tells you which way analysts are leaning; the stock they are most bullish or bearish on, what they are upgrading or downgrades, and where they are betting against the market. Ignore this at your own risk!
EIH clocked consolidated profit of Rs 65.86 crore for the quarter ended June 2022 on normalisation of business, against loss of Rs 114.25 crore in same period last year. In Q1FY22, numbers were affected by second Covid wave. Revenue grew by 314% YoY to Rs 394.3 crore in Q1FY23.
EIH was quoting at Rs 153.90, up Rs 4.30, or 2.87 percent.
Citi View on Bajaj Finance
Research firm Citi has maintained buy rating on the stock with a target at Rs 8,400 per share.
The company reported healthy growth, but settling lower than past levels. The treasury management and pricing helps Net Interest Margin.
The key positive is continued traction in digital products, reported CNBC-TV18.
Multibaggers: These 17 stocks have given high returns in short and long term
A Moneycontrol analysis of BSE 500 stocks showed only 17 stocks have given exceptional returns in last 1-year, 3-year and 5-year periods. SRF, Tata Elxsi and Adani Power figure on the list.
Federal Bank offers special rates for NR Term Deposits
Federal Bank introduces special rates for its NRE Term Deposit. These special rates are available between 28th July 2022 and 4th August 2022. The rates are applicable for NR term deposits opened for a period of 15 months. The new rates offered are 80 bps above the existing rates.
2 Crore and Above
Below 2 Crore
NIIT Q1The company’s Q1 net profit declined 12.6% at Rs 47.7 crore versus Rs 54.6 crore and revenue was up 33.9% at Rs 404.8 crore versus Rs 302.3 crore, YoY.
Dr Lal PathLabs Q1The company has reported 56.4 percent fall in its June quarter (Q1FY23) net profit at Rs 58.2 crore versus Rs 133.7 crore and revenue was down 17.1% at Rs 502.7 crore versus Rs 606.6 crore, YoY.
Geojit on Kotak Mahindra Bank
Healthy asset quality, robust growth in advances, financial prudence backed by strong governance focus and lending growth with reduction in NPA auger well for the bank’s performance going ahead.
We remain confident on its long-term growth prospects.
The stock is currently trading at attractive valuations. Hence, reiterate our BUY rating on the stock with a revised target price of Rs 2,173 based on 3.4x FY24E BVPS.